Holen Sie sich die Stockscreener-App
66.61
0.48%
0.32
Handel nachbörslich:
66.00
-0.61
-0.92%
Schlusskurs vom Vortag:
$66.29
Offen:
$66.29
24-Stunden-Volumen:
1.59M
Relative Volume:
0.95
Marktkapitalisierung:
$11.92B
Einnahmen:
$342.96M
Nettoeinkommen (Verlust:
$-864.29M
KGV:
-12.64
EPS:
-5.27
Netto-Cashflow:
$-636.03M
1W Leistung:
-7.25%
1M Leistung:
-10.64%
6M Leistung:
+168.91%
1J Leistung:
+168.37%
1-Tages-Spanne:
$64.86
$67.25
1-Wochen-Bereich:
$64.86
$74.32
52-Wochen-Spanne:
$21.92
$80.53
Insmed Inc Stock (INSM) Company Profile
Firmenname
Insmed Inc
Sektor
Branche
Telefon
908-977-9900
Adresse
700 US HIGHWAY 202/206, BRIDGEWATER, NJ
Vergleichen Sie INSM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| INSM | 66.61 | 11.92B | 342.96M | -864.29M | -636.03M | -5.27 |
| VRTX | 467.01 | 119.87B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 762.00 | 83.27B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 567.90 | 33.96B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 232.27 | 30.18B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 101.87 | 24.42B | 3.30B | -501.07M | 1.03B | 11.54 |
Insmed Inc Stock (INSM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-02-15 | Eingeleitet | Wolfe Research | Outperform |
| 2023-12-08 | Eingeleitet | Wells Fargo | Overweight |
| 2023-11-20 | Fortgesetzt | JP Morgan | Overweight |
| 2023-07-26 | Eingeleitet | Guggenheim | Buy |
| 2022-12-09 | Eingeleitet | Mizuho | Buy |
| 2022-12-07 | Eingeleitet | Barclays | Overweight |
| 2022-11-18 | Eingeleitet | BofA Securities | Buy |
| 2022-04-27 | Eingeleitet | Goldman | Buy |
| 2021-12-06 | Eingeleitet | JP Morgan | Overweight |
| 2021-10-19 | Fortgesetzt | Monness Crespi & Hardt | Buy |
| 2021-10-19 | Fortgesetzt | Morgan Stanley | Overweight |
| 2021-10-08 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-04-26 | Fortgesetzt | Credit Suisse | Outperform |
| 2020-12-17 | Eingeleitet | Berenberg | Buy |
| 2020-10-12 | Fortgesetzt | Stifel | Buy |
| 2019-09-03 | Eingeleitet | Goldman | Buy |
| 2019-04-09 | Bestätigt | H.C. Wainwright | Buy |
| 2019-02-15 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2019-01-17 | Hochstufung | Goldman | Neutral → Buy |
| 2019-01-02 | Eingeleitet | Canaccord Genuity | Buy |
| 2018-08-06 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2018-07-23 | Eingeleitet | Goldman | Neutral |
| 2018-04-23 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2018-03-21 | Eingeleitet | Morgan Stanley | Overweight |
| 2018-01-18 | Eingeleitet | Credit Suisse | Neutral |
| 2017-09-05 | Bestätigt | Evercore ISI | Outperform |
| 2017-08-17 | Eingeleitet | Evercore ISI | Outperform |
| 2017-07-11 | Eingeleitet | Robert W. Baird | Outperform |
| 2016-03-15 | Eingeleitet | Stifel | Buy |
| 2015-11-09 | Herabstufung | UBS | Buy → Neutral |
| 2015-10-06 | Bestätigt | H.C. Wainwright | Buy |
| 2015-06-09 | Eingeleitet | Citigroup | Neutral |
| 2014-03-26 | Bestätigt | HC Wainwright | Buy |
Alle ansehen
Insmed Inc Aktie (INSM) Neueste Nachrichten
Insmed's Options: A Look at What the Big Money is Thinking - Benzinga
Insmed Incorporated (NASDAQ:INSM) Receives Consensus Rating of "Buy" from Brokerages - MarketBeat
Victory Capital Management Inc. Buys 308,819 Shares of Insmed Incorporated (NASDAQ:INSM) - MarketBeat
WCM Investment Management LLC Purchases 54,806 Shares of Insmed Incorporated (NASDAQ:INSM) - MarketBeat
Notable Monday Option Activity: INSM, MARA, ALGM - Nasdaq
Insmed stock target reduced, keeps Outperform on Q3 report By Investing.com - Investing.com Canada
TimesSquare Capital Management LLC Invests $35.32 Million in Insmed Incorporated (NASDAQ:INSM) - MarketBeat
Principal Financial Group Inc. Acquires 214,130 Shares of Insmed Incorporated (NASDAQ:INSM) - MarketBeat
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet - Benzinga
Fiera Capital Corp Sells 13,112 Shares of Insmed Incorporated (NASDAQ:INSM) - MarketBeat
Van ECK Associates Corp Invests $9.14 Million in Insmed Incorporated (NASDAQ:INSM) - MarketBeat
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Citizentribune
Insmed To Present at November 2024 Investor Conferences - Marketscreener.com
Insmed (INSM) Set for Major Healthcare Conference Circuit: 4 Key Investor Events in November | INSM Stock News - StockTitan
17,682 Shares in Insmed Incorporated (NASDAQ:INSM) Acquired by Harbor Capital Advisors Inc. - MarketBeat
Insmed's SWOT analysis: rare disease biotech stock poised for growth By Investing.com - Investing.com Canada
Insmed's SWOT analysis: rare disease biotech stock poised for growth - Investing.com
New York State Common Retirement Fund Sells 29,520 Shares of Insmed Incorporated (NASDAQ:INSM) - MarketBeat
INSMInsmed, Inc. Latest Stock News & Market Updates - StockTitan
Insmed (INSM) Reliance on International Sales: What Investors Need to Know - Yahoo Finance
Emerald Advisers LLC Buys 49,540 Shares of Insmed Incorporated (NASDAQ:INSM) - MarketBeat
Insmed's Q3 Loss Wider Than Expected, Sales In Line With Estimates - MSN
Insmed (NASDAQ:INSM) Announces Earnings Results - MarketBeat
Insmed Incorporated (NASDAQ:INSM) Q3 2024 Earnings Call Transcript - Insider Monkey
Insmed (INSM) Reports Q3 Loss, Tops Revenue Estimates - MSN
Insmed (INSM) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates - MSN
Earnings call: Insmed reports strong Q3 growth, eyes brensocatib launch - Investing.com
Earnings call: Insmed reports strong Q3 growth, eyes brensocatib launch By Investing.com - Investing.com UK
Do You Believe in the Growth Potential of Insmed (INSM)? - Yahoo Finance
Truist Financial Reaffirms Buy Rating for Insmed (NASDAQ:INSM) - MarketBeat
Insmed Third Quarter 2024 Earnings: EPS Misses Expectations - Yahoo Finance
Decoding Insmed Inc (INSM): A Strategic SWOT Insight - GuruFocus.com
Insmed Inc (INSM) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
Insmed Inc (INSM) Q3 2024 Earnings Call Highlights: Strong Reven - GuruFocus.com
Insmed: Q3 Earnings Snapshot - The Advocate
Insmed (INSM) Reports Q3 Earnings: What Key Metrics Have to Say - Yahoo Finance
Insmed Reports Third-Quarter 2024 Financial Results and Provides Business Update - PR Newswire
How to play biotech stocks: Insmed and Wave Life Sciences - Yahoo Finance
Insmed Incorporated (NASDAQ:INSM) Shares Bought by China Universal Asset Management Co. Ltd. - MarketBeat
Novo Holdings A S Lowers Holdings in Insmed Incorporated (NASDAQ:INSM) - MarketBeat
Insmed Incorporated (NASDAQ:INSM) Shares Acquired by Creative Planning - MarketBeat
Insmed Ranks No. 1 on Science’s 2024 Top Biopharma Employers List - njbmagazine.com
Assenagon Asset Management S.A. Raises Position in Insmed Incorporated (NASDAQ:INSM) - MarketBeat
Insmed's SWOT analysis: stock poised for growth amid challenges - Investing.com India
Insmed Ranks No. 1 on Science's 2024 Top Biopharma Employers List - Citizentribune
Insmed's SWOT analysis: stock poised for growth amid challenges By Investing.com - Investing.com Australia
Finanzdaten der Insmed Inc-Aktie (INSM)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.66%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):